Skip to main content

Cardiovascular Inflammation Reduction Trial (CIRT)

The Cardiovascular Inflammation Reduction Trial (CIRT) is a clinical trial aimed to decrease the risk of heart attacks, strokes, or death in people with type 2 diabetes or metabolic syndrome that have had a heart attack or multiple coronary blockages.


Brigham and Women’s Hospital
National Heart, Lung, and Blood Institute (NHLBI)

Phase: 3

Indication: History of type 2 diabetes or metabolic syndrome

Age: 18 years or older

Category: Treatment

For more information regarding the study:

Studies Currently Available At

Sign Up For This Study